ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1600685

This article is part of the Research TopicIntegrative AI and Multi-Omics: Precision Medicine in Immuno-InflammationView all 6 articles

ScRNA-seq combined with ATAC-seq analysis to explore the metabolic balance mechanism of CCl4-induced liver inflammatory injury

Provisionally accepted
Hui  LiuHui Liu1Yisha  ZhangYisha Zhang2*Shoubin  NingShoubin Ning1*
  • 1Department of Gastroenterology, Air Force Medical Center, Air Force Medical University, Beijing, China, Beijing, China
  • 2Department of Internal Medicine, First Rongjun Youfu Hospital of Shandong Province, Jinan, China, Jinan, China

The final, formatted version of the article will be published soon.

Background: Drug-induced liver injury (DILI) can provoke inflammation and fibrosis in the liver, potentially leading to severe liver diseases and mortality; however, effective treatments for liver fibrosis remain elusive. The objective of this study was to explore the cellular metabolic mechanism after carbon tetrachloride (CCl4)-induced liver injury. Methods: Initially, we conducted a comprehensive analysis of ATAC-seq, RNA-seq, and scRNA-seq datasets derived from CCl4-induced chronic liver injury in mice. Subsequently, functional enrichment analysis and transcription factor analysis were performed. Finally, the expression changes of key substances and transcription factors were verified by cell and animal experiments. Results: Our investigation uncovered that hepatocyte histone acetylation intensified with prolonged injury durations. Subsequent functional enrichment analysis showed that fatty acid metabolism as the predominant pathway implicated in hepatocyte damage. The tricarboxylic acid cycle in hepatocytes exhibited partial slowdown and the mitochondrial electron transport chain (ETC) was inhibited in the early stage of CCl4-induced chronic injury. However, in the later stage of injury, there was a gradual restoration of the ETC functionality, coupled with an enhanced capacity for de novo synthesis of fatty acids. This process of metabolic equilibrium restoration may be related to the acute accumulation of lipids in liver injury repair. Transcription factor analysis found that Zhx2, a crucial suppressor of ETC, experienced sustained increases in chromatin accessibility within injured hepatocytes, but its expression level increased first and then decreased. The key transcriptional repressor Zbtb20 could inhibit the expression of Zhx2, and its expression trend corresponded to that of Zhx2. Cellular experiments demonstrated that CCl4 induced upregulation of acetyl-CoA, Zhx2 and Zbtb20 in a time-dependent manner. The levels of acetyl-CoA and Zbtb20 increased with the duration of injury in animal experiments, but Zhx2 showed a rise in expression only at week 3, while expression returned to normal levels after week 6.Conclusion: Our findings contribute to the understanding of the evolution and underlying CCl4-induced inflammatory mechanisms governing hepatocyte inflammatory injury and the subsequent metabolic shift from imbalance toward balance under chronic CCl4 exposure, offering novel perspectives and directions for targeted therapeutic interventions in DILI.

Keywords: CCl4, Chronic liver injury, histone acetylation, fatty acid metabolism, ZHX2, ZBTB20

Received: 26 Mar 2025; Accepted: 14 May 2025.

Copyright: © 2025 Liu, Zhang and Ning. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yisha Zhang, Department of Internal Medicine, First Rongjun Youfu Hospital of Shandong Province, Jinan, China, Jinan, China
Shoubin Ning, Department of Gastroenterology, Air Force Medical Center, Air Force Medical University, Beijing, China, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.